Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

The neuropathology of fatal encephalomyelitis in human Borna virus infection.

Liesche F, Ruf V, Zoubaa S, Kaletka G, Rosati M, Rubbenstroth D, Herden C, Goehring L, Wunderlich S, Wachter MF, Rieder G, Lichtmannegger I, Permanetter W, Heckmann JG, Angstwurm K, Neumann B, Märkl B, Haschka S, Niller HH, Schmidt B, Jantsch J, Brochhausen C, Schlottau K, Ebinger A, Hemmer B, Riemenschneider MJ, Herms J, Beer M, Matiasek K, Schlegel J.

Acta Neuropathol. 2019 Oct;138(4):653-665. doi: 10.1007/s00401-019-02047-3. Epub 2019 Jul 26.

2.

Truncated oncoproteins of retroviruses and hepatitis B virus: A lesson in contrasts.

Minarovits J, Niller HH.

Infect Genet Evol. 2019 Sep;73:342-357. doi: 10.1016/j.meegid.2019.05.020. Epub 2019 May 29. Review.

PMID:
31152910
3.

Fatal Encephalitic Borna Disease Virus 1 in Solid-Organ Transplant Recipients.

Schlottau K, Forth L, Angstwurm K, Höper D, Zecher D, Liesche F, Hoffmann B, Kegel V, Seehofer D, Platen S, Salzberger B, Liebert UG, Niller HH, Schmidt B, Matiasek K, Riemenschneider MJ, Brochhausen C, Banas B, Renders L, Moog P, Wunderlich S, Seifert CL, Barreiros A, Rahmel A, Weiss J, Tappe D, Herden C, Schmidt-Chanasit J, Schwemmle M, Rubbenstroth D, Schlegel J, Pietsch C, Hoffmann D, Jantsch J, Beer M.

N Engl J Med. 2018 Oct 4;379(14):1377-1379. doi: 10.1056/NEJMc1803115. No abstract available.

PMID:
30281984
4.

Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors.

Kiener R, Fleischmann M, Wiegand MA, Lemmermann NAW, Schwegler C, Kaufmann C, Renzaho A, Thomas S, Felder E, Niller HH, Asbach B, Wagner R.

J Virol. 2018 Jul 17;92(15). pii: e00569-18. doi: 10.1128/JVI.00569-18. Print 2018 Aug 1.

5.

Pathogenic mechanisms of intracellular bacteria.

Niller HH, Masa R, Venkei A, Mészáros S, Minarovits J.

Curr Opin Infect Dis. 2017 Jun;30(3):309-315. doi: 10.1097/QCO.0000000000000363. Review.

PMID:
28134679
6.

Tick-borne encephalitis virus neutralization by high dose intravenous immunoglobulin.

Elsterova J, Palus M, Sirmarova J, Kopecky J, Niller HH, Ruzek D.

Ticks Tick Borne Dis. 2017 Feb;8(2):253-258. doi: 10.1016/j.ttbdis.2016.11.007. Epub 2016 Nov 18.

PMID:
27884572
7.

Epstein-Barr Virus: Clinical Diagnostics.

Niller HH, Bauer G.

Methods Mol Biol. 2017;1532:33-55. Review.

PMID:
27873265
8.

Current Trends and Alternative Scenarios in EBV Research.

Minarovits J, Niller HH.

Methods Mol Biol. 2017;1532:1-32. Review.

PMID:
27873264
9.

Patho-epigenetics of Infectious Diseases Caused by Intracellular Bacteria.

Niller HH, Minarovits J.

Adv Exp Med Biol. 2016;879:107-130. doi: 10.1007/978-3-319-24738-0_6. Review.

PMID:
26659266
10.

Epigenetic Dysregulation in Virus-Associated Neoplasms.

Minarovits J, Demcsák A, Banati F, Niller HH.

Adv Exp Med Biol. 2016;879:71-90. doi: 10.1007/978-3-319-24738-0_4. Review.

PMID:
26659264
11.

Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.

Niller HH, Banati F, Salamon D, Minarovits J.

Adv Exp Med Biol. 2016;879:39-69. doi: 10.1007/978-3-319-24738-0_3. Review.

PMID:
26659263
12.

Epigenetic Regulation.

Minarovits J, Banati F, Szenthe K, Niller HH.

Adv Exp Med Biol. 2016;879:1-25. doi: 10.1007/978-3-319-24738-0_1. Review.

PMID:
26659261
13.

Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.

Niller HH, Ay E, Banati F, Demcsák A, Takacs M, Minarovits J.

Rev Med Virol. 2016 Jan;26(1):57-73. doi: 10.1002/rmv.1864. Epub 2015 Nov 23. Review.

PMID:
26593760
14.

MRI-imaging and clinical findings of eleven children with tick-borne encephalitis and review of the literature.

von Stülpnagel C, Winkler P, Koch J, Zeches-Kansy C, Schöttler-Glas A, Wolf G, Niller HH, Staudt M, Kluger G, Rostasy K.

Eur J Paediatr Neurol. 2016 Jan;20(1):45-52. doi: 10.1016/j.ejpn.2015.10.008. Epub 2015 Nov 9.

PMID:
26586340
15.

Epstein-Barr virus-host cell interactions: an epigenetic dialog?

Niller HH, Szenthe K, Minarovits J.

Front Genet. 2014 Oct 21;5:367. doi: 10.3389/fgene.2014.00367. eCollection 2014.

16.

Role of epigenetics in EBV regulation and pathogenesis.

Niller HH, Tarnai Z, Decsi G, Zsedényi A, Bánáti F, Minarovits J.

Future Microbiol. 2014;9(6):747-56. doi: 10.2217/fmb.14.41. Review.

PMID:
25046522
17.

Epigenetics of HIV infection: promising research areas and implications for therapy.

Ay E, Banati F, Mezei M, Bakos A, Niller HH, Buzás K, Minarovits J.

AIDS Rev. 2013 Jul-Sep;15(3):181-8. Review.

PMID:
24002202
18.
19.

The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.

Szenthe K, Koroknai A, Banati F, Bathori Z, Niller HH, Wolf H, Nagy N, Klein E, Minarovits J, Salamon D.

Biochem Biophys Res Commun. 2013 May 24;435(1):8-15. doi: 10.1016/j.bbrc.2013.03.127. Epub 2013 Apr 10.

PMID:
23583387
20.

The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.

Szenthe K, Koroknai A, Banati F, Bathori Z, Lozsa R, Burgyan J, Wolf H, Salamon D, Nagy K, Niller HH, Minarovits J.

Biochem Biophys Res Commun. 2013 Apr 19;433(4):489-95. doi: 10.1016/j.bbrc.2013.03.022. Epub 2013 Mar 23.

PMID:
23528241
22.

Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease.

Niller HH, Wolf H, Ay E, Minarovits J.

Adv Exp Med Biol. 2011;711:82-102. Review.

PMID:
21627044
23.

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges.

Kittan NA, Beier F, Kurz K, Niller HH, Egger L, Jilg W, Andreesen R, Holler E, Hildebrandt GC.

Transpl Infect Dis. 2011 Oct;13(5):524-30. doi: 10.1111/j.1399-3062.2011.00621.x. Epub 2011 Mar 13.

PMID:
21395956
24.
25.

Viral hit and run-oncogenesis: genetic and epigenetic scenarios.

Niller HH, Wolf H, Minarovits J.

Cancer Lett. 2011 Jun 28;305(2):200-17. doi: 10.1016/j.canlet.2010.08.007. Epub 2010 Sep 1. Review.

PMID:
20813452
26.

Epigenetic regulation of latent Epstein-Barr virus promoters.

Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Review.

PMID:
19853674
27.

Library of prefabricated locked nucleic acid hydrolysis probes facilitates rapid development of reverse-transcription quantitative real-time PCR assays for detection of novel influenza A/H1N1/09 virus.

Wenzel JJ, Walch H, Bollwein M, Niller HH, Ankenbauer W, Mauritz R, Höltke HJ, Zepeda HM, Wolf H, Jilg W, Reischl U.

Clin Chem. 2009 Dec;55(12):2218-22. doi: 10.1373/clinchem.2009.136192. Epub 2009 Oct 1.

28.

Detection of influenza A(H1N1)v virus by real-time RT-PCR.

Panning M, Eickmann M, Landt O, Monazahian M, Olschläger S, Baumgarte S, Reischl U, Wenzel JJ, Niller HH, Günther S, Hollmann B, Huzly D, Drexler JF, Helmer A, Becker S, Matz B, Eis-Hübinger A, Drosten C.

Euro Surveill. 2009 Sep 10;14(36). pii: 19329.

29.

Inhibition of Legionella pneumophila PCR in respiratory samples: a quantitative approach.

Kern M, Böhm S, Deml L, Wolf H, Reischl U, Niller HH.

J Microbiol Methods. 2009 Nov;79(2):189-93. doi: 10.1016/j.mimet.2009.08.020. Epub 2009 Sep 10.

PMID:
19747952
30.

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

Niller HH, Wolf H, Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Review.

PMID:
19429479
31.

First sequence-confirmed case of infection with the new influenza A(H1N1) strain in Germany.

Melzl H, Wenzel JJ, Kochanowski B, Feierabend K, Kreuzpaintner B, Kreuzpaintner E, Rohrhofer A, Schreder-Meindl S, Wollner H, Salzberger B, Reischl U, Jilg W, Wolf H, Niller HH.

Euro Surveill. 2009 May 7;14(18). pii: 19203. Erratum in: Euro Surveill. 2009;14(19). doi: 19208. Kochanowski, B [added].

32.

Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.

Salamon D, Banati F, Koroknai A, Ravasz M, Szenthe K, Bathori Z, Bakos A, Niller HH, Wolf H, Minarovits J.

J Gen Virol. 2009 May;90(Pt 5):1183-9. doi: 10.1099/vir.0.007344-0. Epub 2009 Mar 4.

PMID:
19264589
33.

The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J.

Mediterr J Hematol Infect Dis. 2009 Nov 15;1(2):e2009012. doi: 10.4084/MJHID.2009.012.

34.

Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.

Fejer G, Koroknai A, Banati F, Györy I, Salamon D, Wolf H, Niller HH, Minarovits J.

J Gen Virol. 2008 Jun;89(Pt 6):1364-70. doi: 10.1099/vir.0.83594-0.

PMID:
18474551
35.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
36.

CpG-methylation silences the activity of the RNA polymerase III transcribed EBER-1 promoter of Epstein-Barr virus.

Banati F, Koroknai A, Salamon D, Takacs M, Minarovits-Kormuta S, Wolf H, Niller HH, Minarovits J.

FEBS Lett. 2008 Mar 5;582(5):705-9. doi: 10.1016/j.febslet.2008.01.042. Epub 2008 Feb 5.

37.

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D.

J Virol. 2007 Dec;81(23):13242-7. Epub 2007 Sep 26.

38.

High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J.

Virus Genes. 2007 Oct;35(2):195-202. Epub 2007 May 18.

PMID:
17510783
39.

A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review.

Niller HH, Salamon D, Rahmann S, Ilg K, Koroknai A, Bánáti F, Schwarzmann F, Wolf H, Minárovits J.

Acta Microbiol Immunol Hung. 2004;51(4):469-84.

PMID:
15704335
40.

The LCR of EBV makes Burkitt's lymphoma endemic.

Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J.

Trends Microbiol. 2004 Nov;12(11):495-9.

PMID:
15488390
41.

EBV-associated neoplasms: alternative pathogenetic pathways.

Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J.

Med Hypotheses. 2004;62(3):387-91.

PMID:
14975509
42.

Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia.

Speer G, Tóth M, Niller HH, Salamon D, Takács I, Miheller P, Patócs A, Nagy Z, Bajnok E, Nyiri P, Lakatos P.

Exp Clin Endocrinol Diabetes. 2003 Dec;111(8):486-90.

PMID:
14714270
43.

Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation.

Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, Krause SW.

J Biol Chem. 2003 Nov 7;278(45):44058-67. Epub 2003 Aug 20.

44.
45.

Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, Farrell PJ.

J Gen Virol. 2003 Jun;84(Pt 6):1443-50.

PMID:
12771413
46.

The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.

Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J.

Med Sci Monit. 2003 Jan;9(1):HY1-9.

PMID:
12552250
47.

Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae.

Linde HJ, Notka F, Irtenkauf C, Decker J, Wild J, Niller HH, Heisig P, Lehn N.

J Antimicrob Chemother. 2002 Apr;49(4):625-30.

PMID:
11909836
48.

Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Niller HH, Salamon D, Uhlig J, Ranf S, Granz M, Schwarzmann F, Wolf H, Minarovits J.

J Virol. 2002 Apr;76(8):4113-8.

49.

NS1 protein of parvovirus B19 interacts directly with DNA sequences of the p6 promoter and with the cellular transcription factors Sp1/Sp3.

Raab U, Beckenlehner K, Lowin T, Niller HH, Doyle S, Modrow S.

Virology. 2002 Feb 1;293(1):86-93.

50.

Supplemental Content

Loading ...
Support Center